IRR samplea | Criterion validity samplea | Total sample | |
---|---|---|---|
N | 54 | 132 | 243 |
Age, years | |||
Mean (SD) | 41.48 (12.15) | 44.67 (11.89) | 44.22 (12.64) |
Range | 23–66 | 22–69 | 18–78 |
Sex (n, %) | |||
Male | 24 (44.44) | 57 (43.18) | 96 (39.51) |
Female | 30 (55.66) | 75 (56.82) | 147 (60.49) |
Duration of current MDD episode (n, %) | |||
Acute (≤12 months) | 27 (50.00) | 56 (42.42) | 108 (44.45) |
Subacute (13–24 months) | 7 (12.96) | 13 (9.85) | 28 (11.52) |
Chronic (> 24 months) | 20 (37.04) | 63 (47.73) | 107 (44.03) |
Symptom severity of current MDD episode (n, %) | |||
Mild | 14 (25.93) | 24 (18.18) | 48 (19.75) |
Moderate | 25 (46.30) | 47 (35.61) | 89 (36.63) |
Severe without psychosis | 11 (20.37) | 49 (37.12) | 85 (34.98) |
Severe with psychosis | 4 (7.41) | 12 (9.09) | 21 (8.64) |
Total DTUD score | |||
Mean (SD) | 3.85 (1.85) | 3.65 (2.05) | 3.70 (2.00) |
Range | 0.00–8.00 | 0.00–9.00 | 0.00–9.00 |
Total MSM score | |||
Mean (SD) | 6.02 (2.16) | 6.98 (2.42) | 6.71 (2.42) |
Range | 3.00–13.00 | 3.00–13.00 | 3.00–13.00 |
Total DM-TRD score | |||
Mean (SD) | 10.55 (3.13) | 11.60 (3.97) | 11.30 (3.67) |
Range | 6.00–23.50 | 3.00–23.50 | 3.00–23.50 |